Annual Research Seminar
49th Annual Radiation Oncology Research Seminar
February 22 – 23, 2019
Hilton University of Florida Conference Center
You are cordially invited to the 49th Annual Research Seminar, which will take place February 22-23, 2019 at the Hilton University of Florida Conference Center. The Seminar is an important venue that allows us to define optimal treatment approaches, produce the best plans, employ first-rate techniques, provide healing experiences for our patients, assess outcomes, and develop new treatment approaches, providing invaluable information to faculty and residents from several educational institutions as well as professionals in private practice. The seminar will provide breakfast, lunch and a reception for all attendees on Friday, February 22.
The 2019 Keynote Speaker will be David E. Wazer, MD, FACRO, FABS, FACR, FASTRO, director of the Lifespan Cancer Institute of Rhode Island, The Miriam and Newport hospitals, as well as radiation oncologist-in-chief at Rhode Island Hospital. He is professor and chairman of the departments of radiation oncology at both The Warren Alpert Medical School of Brown University and Tufts University School of Medicine.
Dr. Wazer is an internationally recognized expert in the application of new technology in the field of radiation oncology. He has published more than 200 scientific articles, written several books, and is also editor-in-chief of the American Journal of Clinical Oncology. His specialties include postlumpectomy radiotherapy for breast preservation; melanomas, including ocular melanoma; gastrointestinal carcinoma; and stereotactic radiotherapy and radiosurgery.
Wazer earned his medical degree (with honors) from the New York University School of Medicine, New York, NY, and also completed a research fellowship in neurochemistry at New York University. Dr. Wazer obtained his clinical training in internal medicine at Brown University and in radiation oncology at Tufts University. His clinical research interests include the study of the efficacy, toxicity, and cost/utility analysis of image-guided radiation therapy, partial breast irradiation, electronic brachytherapy and hyperthermia. He is actively involved in the development of clinical trials for cancers of the breast, skin, gastrointestinal tract and lung.
Dr. Wazer is a fellow of the American Society for Radiation Oncology and the American College of Radiation Oncology and a member of the Radiation Research Society, American Society of Clinical Oncology, the American College of Radiology, the American Radium Society, the American Association for the Advancement of Science and the American Brachytherapy Society.
Topics will include: Survival outcomes after radiotherapy treatment for head and neck, breast, thyroid, skin, and genitourinary cancers; sarcomas; lymphomas; and central nervous system tumors, among other disease sites | Quality of life, and its clinical assessment, in patients who receive radiotherapy | Proton therapy techniques and outcomes in adult and pediatric tumors | Treatment toxicities, emergent patient needs, and survivorship.
Presenters will typically present the results of IRB-approved studies conducted throughout the year that focus on monitoring and analyzing the outcomes of patients who have received radiotherapy at UF. There are also presentations by faculty that are broad overviews of certain disease systems, and what role radiotherapy can and should play in treatment of the condition.
At the conclusion of this activity, participants should be able to:
- Describe techniques and results of treatment of head and neck, pediatric cancers, lung cancer, and other tumors at the University of Florida Department of Radiation Oncology and the University of Florida Proton Therapy Institute.
- Explain treatment methods to manage treatment side effects and reduce the occurrence of late complications of treatment.
- Recognize and interpret the success rates UF is experiencing with its radiotherapy techniques
Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit: The University of Florida College of Medicine designates this live activity for a maximum of 11 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For more information
Contact Jessica Kirwan at (352) 265-8832 with any questions regarding the event or accommodations.
For past meetings, click here.